To estimate the association between LINC02432/hsa-miR-98–5p/HK2 axis and clinical prognosis, all 177 TCGA PAAD samples were randomly divided into a training cohort (n = 133) and a testing cohort (n = 44) at a ratio of 3:1. This evidence concerns the gene HK2 and pancreatic adenocarcinoma.